期刊文献+

2型糖尿病大血管病变患者血清IL-17水平变化及意义 被引量:13

The expression levels of serum interleukin-17 in type 2 diabetes with macroangiopathy
暂未订购
导出
摘要 目的探讨2型糖尿病(T2DM)大血管病变患者血清IL-17的表达水平及意义。方法 162例T2DM患者,根据是否合并大血管病变,分为大血管病变组90例和无血管病变组72例,另选同期健康查体者68例作为正常对照组。采用酶联免疫吸附法(ELISA)测定三组人群空腹静脉血中IL-17水平,统计IL-17与各临床指标间的关系,分析其影响因素。同时,根据T2DM大血管病变患者颈动脉内膜中层厚度,探讨有无颈动脉增厚对IL-17水平的影响。结果 T2DM合并大血管病变组血清IL-17水平显著高于无血管病变组及正常对照组,T2DM无大血管病变组高于正常对照组(P<0.01)。T2DM大血管病变患者中,颈动脉增厚组IL-17水平明显高于无颈动脉增厚组(P<0.05)。在大血管病变组IL-17与BMI、2 h PG、hs-CRP、TG、LDL-C呈正相关,而与HDL-C呈负相关。多元逐步回归分析显示IL-17、hs-CRP和LDL-C是T2DM大血管病变的主要影响因素。结论T2DM大血管病变组和颈动脉增厚组血清IL-17表达均增高,提示IL-17参与糖尿病大血管病变的炎症反应过程。IL-17可能是T2DM大血管病变的独立危险因素,在糖尿病大血管病变发生、发展中发挥重要作用。 Objective To study the expression levels of serum interleukin-17(IL-17) in type 2 diabetes mellitus(T2DM) with macroangiopathy,and to carry out the correlation analysis between these two factors.Methods A total of 162 patients diagnosed of T2DM were divided into two groups according to the macrovascular complications,90 cases with macroangiopathy and 72 cases without macroangiopathy,another 68 healthy persons were enrolled in control group.Serum level of IL-17 was measured by enzyme linked immunosorbent assay(ELISA),the relationship between IL-17 and other impact factors was statistically analyzed.Meanwhile,according to the presence or absence of the thickening of carotid intima-media thickness(IMT),T2DM macroangiopathy patients were then assigned into another two groups to compare the IL-17 levels.Results The levels of serum IL-17 in T2DM with and without macroangiopathy groups were significantly higher than those of control group,and the differences from those of T2DM groups were also statistically significant(P0.05).The level of IL-17 in T2DM with carotid thickening group was largely increased compared with that of non-thickening group(P0.05).In T2DM with macroangiopathy group,the level of IL-17 was positively correlated with BMI,2 h PG,hs-CRP,TG,LDL-C and negatively correlated with HDL-C.Stepwise regression analysis showed that IL-17,hs-CRP and HDL-C were the main factors for T2DM macroangiopathy.Conclusions The serum IL-17 expression levels of T2DM with macroangiopathy and carotid thickening groups are elevated,which suggest that IL-17 might be involved in the process of inflammatory response to diabetic macroangiopathy.IL-17 might be an independent risk factor for T2DM macroangiopathy,and play a vital role in the onset and development of diabetic vascular diseases.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第13期3024-3026,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金面上项目(No.31171129) 上海市科委科技发展基金基础研究重点课题(No.10JC1404800)
关键词 IL-17 2型糖尿病 大血管病变 IL-17 Type 2 diabetes Macroangiopathy
  • 相关文献

参考文献12

  • 1Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4 + effeetor T cells develop via a lineage distinct from the T helper type 1 and 2 lineages [ J ]. Nat Immunol,2005 ,6 ( 11 ) : 1123-32.
  • 2Venkatachalam K, Mummidi S, Cortez DM, et al. Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts[ J]. Am J Physiol Heart Circ Physiol, 2008,294(5) :142078-87.
  • 3汪海东,孙皎,夏世金.IL-17和siRNA-IL-17基因逆转录病毒载体的构建及其转染致糖尿病性T细胞中IL-17的表达[J].中国老年学杂志,2009,29(22):2873-2877. 被引量:6
  • 4Vasan RS, Kannel WB. Recent US and European blood pressure guide- lines : implications for developing countries [ J ]. Natl Med J India, 2003 , 16(5) :241-4.
  • 5Villeneuve LM, Natarajan R. The role of epigenetics in the pathology of diabetic complications[ J]. Am J Physiol Renal Physiol, 2010 , 299 ( 1 ) : F14-25.
  • 6Averill MM, Bornfeldt KE. Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes [ J ]. Curr Diab Rep, 2009 ,9 ( 1 ) :18-25.
  • 7Castoldi G, Galimberti S, Riva C, et al. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes[ J]. Clin Sci(Lond) ,2007 ,113(2) :103-8.
  • 8Ji Y,Zhang W. Thl7 cells:positive or negative role in tumor[ J] ? Cancer Immunol Immunother,2010 ,59 ( 7 ) :979-87.
  • 9Vukkadapu SS, Belli JM, Ishii K, et al. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to auto- immune diabetes of the NOD mouse [ J]. Physiol Genomics, 2005, 21 (2) :201-11.
  • 10田小平,徐宁,惠媛,杨海燕,苏彩女,庄慧芹.初诊2型糖尿病患者血清炎性细胞因子的表达[J].江苏医药,2011,37(13):1576-1578. 被引量:4

二级参考文献37

  • 1Sakoda M,Ichihara A,Kurauchi-Mito A,Narita T,Kinou-chi K,Murohashi-Bokuda K,Saleem MA,Nishiyama A,Suzuki F,Itoh H,黄晓斌.在不影响人足细胞(前)肾素受体信号下,阿利吉仑能抑制细胞内血管紧张素Ⅱ水平[J].中华高血压杂志,2010,18(7):698-698. 被引量:18
  • 2姚琦,袁丁.IL-17在类风湿关节炎中的研究进展[J].江苏医药,2007,33(1):68-69. 被引量:14
  • 3Wynn TA. T(H)-17:a giant step from T(H)I and T(H)2[J].Nat Immunol,2005 ;6 ( 11 ) :1069-70.
  • 4Kolls JK, Linden A. Interleukin-17 family members and inflammation [J]. Immunity,2004;21 (4) :467-76.
  • 5Wang B, Gonzalez A, Benoist C, et al. The role of CD8^+ T cells in the in- itiation of insulin-dependent diabetes mellitus[J]. Eur J Immunol, 1996; 26(8) :1762-9.
  • 6Mitchell TC, Hildeman D, Kedl RM, et al. Immunological adjuvants promote activated T cell survival via induction of Bcl-3 [J]. Nat Immunol, 2001 ;2(5) :397-402.
  • 7Phillips JM,Haskins K,Cooke A. MAdCAM-1 is needed for diabetes development mediated by the T cell clone, BDC-2. 5[J].Immunology, 2005 ;116(4) :525-31.
  • 8Vukkadapu SS, Belli JM, Ishii K, et al. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to auto- immune diabetes of the NOD mouse [J]. Physiol Genomics, 2005 ; 21(2) :201-11.
  • 9Hui EK ,Yap EM ,An DS ,et al. Inhibition of influenza virus matrix ( M1 ) protein expression and virus replication by U6 promoter-driven and lenti- virus- mediated delivery of siRNA[J].J Gen Virol, 2004 ; 85 ( 7 ) : 1877-84.
  • 10Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes[J], Diabetes Care, 2004,27 (3):813-823.

共引文献8

同被引文献93

  • 1李霞,周智广,亓海英,陈小燕,黄干.用空腹C肽代替胰岛素改良Homa公式评价胰岛素抵抗和胰岛β细胞功能[J].中南大学学报(医学版),2004,29(4):419-423. 被引量:221
  • 2白洁,司淑芳,张改英.血清A-FABP及炎性因子对糖尿病大血管并发症的影响[J].山东医药,2010,50(50):89-90. 被引量:4
  • 3Pauer J, Fek A, Buday B, et al. metabolic alteration in healthy men with first degree type 2 diabetic relatives [J]. Orv Hetil, 2013,154(5) :178-186.
  • 4Pietraszek A, Gregersen S, Hermansen K. Acute effects of di- etary fat on inflammatory markers and gene expression in first- degree relatives of type 2 diabetes patients [J]. Rev Diabet Stud, 2011,8(4) :477-489.
  • 5Jager LD, Dabelic R, Waiboci LW, et al. The kinase inhibitory region of socs-1 is sufficient to inhibit t-helper 17 and other im- mune functions in experimental allergic encephalomyelitis [J]. J Neuroimmunol, 2011,232(1-2) : 108-118.
  • 6中华医学会糖尿病学分会.中国2型糖尿病防治指南[M].北京:北京大学医学出版社,2013:447-498.
  • 7袁惠敏,张江蓉,赵烨,等.老年2型糖尿病血清铁蛋白和超敏C反应蛋白与颈动脉内中膜厚度的相关性分析[J].中国医师杂志,2014,(z2):10-12.
  • 8Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, inter- leukin 6, and risk of developing type 2 diabetes mellitus[ J ]. JA- MA ,2001,286 ( 3 ) :327-334.
  • 9Moseley TA, Haudenschild DR, Rose L,et al. Interleukin-17 fam- ily and IL-17 receptors[ J ]. Cytokine Growth Factor Rev,2003,4 (2) :155-174.
  • 10代莉,谭春萍,李洪,等.血清IL-17水平与2型糖尿病及血管病变的关系[J].中华临床医师杂志,2012,20(6):6363-6365.

引证文献13

二级引证文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部